about
Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.Degeneration of the organ of Corti following intravenous administration of cisplatin.Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue.Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti culturesWeight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study.Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes.Voice and quality of life in patients with recurrent respiratory papillomatosis in a northern Sweden cohort.Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy.Blood flow-independent accumulation of cisplatin in the guinea pig cochlea.Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.Tubulin α-6 chain is a stably expressed reference gene in archival samples of normal oral tissue and oral squamous cell carcinoma.Gene expression profiling of archival tongue squamous cell carcinomas provides sub-classification based on DNA repair genes.Changes in intimate relationships following treatment for head and neck cancer - a qualitative study.The experience of food, eating and meals following radiotherapy for head and neck cancer: a qualitative study.Immunohistochemical analysis of EGFR and hyaluronan in tongue cancer and the development of regional recurrence in patients initially diagnosed N0.p63 Transcriptionally regulates BNC1, a Pol I and Pol II transcription factor that regulates ribosomal biogenesis and epithelial differentiation.Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins.Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig.D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics.Evaluation of anesthesia effects in a rat animal model using otoacoustic emission protocols.Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.Intracochlear administration of thiourea protects against cisplatin-induced outer hair cell loss in the guinea pig.Radiation-induced trismus in the ARTSCAN head and neck trial.Changes of stapedius reflex and hearing threshold in patients receiving high-dose cisplatin treatment.Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up.High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig model.Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.Intact blood-perilymph barrier in the rat after impulse noise trauma.Cisplatin-induced metabolome changes in serum: an experimental approach to identify markers for ototoxicity.Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy.Complications in translabyrinthine surgery of vestibular schwannoma.The management and survival outcomes of nasopharyngeal cancer in the Nordic countries.Low-dose, long-term caroverine administration attenuates impulse noise-induced hearing loss in the rat.Ototoxic effects of cisplatin in a Sprague-Dawley rat animal model as revealed by ABR and transiently evoked otoacoustic emission measurements.Extensive lead exposure in children living in an area with production of lead-glazed tiles in the Ecuadorian Andes.Susceptibility to impulse noise trauma in different species: guinea pig, rat and mouse.Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin.High-dose cisplatin treatment: hearing loss and plasma concentrations.Ototoxicity of cisplatin.
P50
Q30455292-1624C9DC-B7BD-4AB6-8891-41B03DC4B4C9Q33289056-CA531D34-ADC2-4996-85EB-A5366ADF2762Q33562569-90AB6E9F-D4F8-4D80-9898-1B301F4055A1Q33630058-84F39D30-479E-4809-8248-35666F9E73ECQ33958563-D8443E19-679A-4597-9ADC-D4EC52317B18Q34243648-64F62E10-F7B4-49C9-9AAE-9326FD67E303Q35085330-1A69DA20-9108-49FB-8453-A16F459BC14BQ36754572-DEE9FC04-2947-4BEF-9242-2FCBC7DD97BAQ36847292-AE5A62E4-3506-4D22-ADBC-9734E0B9D997Q37004759-324C02C9-A586-44DD-BAFE-96999FCD72AEQ38416786-302EC8C5-F5B9-4B50-9ADF-DB1725E51975Q38419364-6DDCADD3-E682-4275-A834-DD8140D6D70AQ38557436-952C88CA-88D7-4959-B93D-78C5597AA339Q38565805-A04E6756-4419-4E40-9088-21EACA60C291Q38868664-4D278070-A1E9-4948-B02C-F08BD10BA676Q39509863-5860982D-8159-4CC5-92BE-EC453D7EAEC3Q42022792-F06C4B78-0C4F-4ED0-A9DD-15D6386B70B2Q42507530-C76DD35B-24D3-4DE2-80DA-2DC95AFC7A31Q44006638-EFBC6C08-F380-4203-8F19-E6569B0D931AQ44123540-37C96667-88FA-4BF2-87AC-DDE8AA322272Q44259310-4BA1E029-4BF3-44EC-8DFA-EEC05C4C92E2Q44509560-209DA0EC-A92E-4EC3-BDF7-CBE93D307444Q44718363-0AA42539-1136-4576-BF4C-E15B6A5CED92Q44790775-D101FB21-BD62-4A66-9D50-3B86B6694003Q44801239-A3628F35-BACA-443E-A8CD-34C17450043EQ45099684-A2F79152-CB41-4D8C-90EF-523FD5ADBA67Q46174330-DBB0C03C-8FD1-4C7C-ACB4-D8E8C2DD958EQ46204838-BD15F5E3-ED65-47FE-9B21-6C607054E45FQ46528260-9AA3F34D-1A37-4333-AAB1-7B26A5C04AD5Q46891118-DA6E54E0-DE10-4AA7-9B5B-4BF478294E0EQ47172240-7E8F878F-1187-48D8-80ED-93FE685710A5Q48182053-4523B659-D5A5-48B0-93FD-3D3572216C76Q48185284-06D112DD-0672-4F88-B283-7FCA27D8C830Q48393060-CA5D1C44-1CB5-4AED-A7CD-4730F1BEA62AQ48495081-3F89880B-EE87-47F1-84F8-39D9FB3C9A40Q50112217-25AA73CF-5B58-4CAC-BFBC-7CA3C4CD02DCQ50455410-2E8E9AD8-0153-4EBB-8F36-FF6E5BE8C152Q50530085-D677656F-ED15-4AC4-B527-38857CA81054Q50550212-5256A567-4E22-4F8E-BC03-BD2F4DA65CDFQ50575498-09330929-1080-4A41-9646-C68E1D5371CF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Göran Laurell
@ast
Göran Laurell
@en
Göran Laurell
@es
Göran Laurell
@nl
type
label
Göran Laurell
@ast
Göran Laurell
@en
Göran Laurell
@es
Göran Laurell
@nl
prefLabel
Göran Laurell
@ast
Göran Laurell
@en
Göran Laurell
@es
Göran Laurell
@nl
P1006
P214
P906
P1006
P106
P214
P31
P496
0000-0002-7760-246X
P569
1954-01-01T00:00:00Z
P735
P7859
lccn-no2004120336